Norepinephrine Bitartrate Injection USP 4 mg/4 mL
Lack of Assurance of Sterility
Every FDA drug recall initiated in 2021, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,152 recalls, newest first.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Complaint received of foreign matter (metal) embedded in tablet.
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Superpotent and Failed Tablet/Capsule Specifications
Failed Impurities/Degradation Specifications
Out-of-specification impurity test result observed at 18-month long term stability time point.
CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Defective Delivery System
Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.
Lack of Assurance of Sterility
Microbial Contamination of Non-Sterile Product
Failed impurities/degradation specifications
Failed Dissolution Specifications
Subpotent
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.
Defective Container: Leaking containers.
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCT: microbial contaminant identified as Pluralibacter gergoviae.
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations